Computational approach towards Identification of Functional Mutations in Il-6 Cytokine Family and It’s Putative Association with Head and Neck Squamous Cell Carcinoma
Aklesha Behera1, Vijayashree Priyadharsini J2*, Abilasha R3
1 Department of Oral Pathology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University,
India.
2 Assistant Professor, Department of Microbiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences,
Saveetha University, India.
3 Reader, Department of oral pathology, Saveetha dental college and hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University,
Chennai-600077, India.
*Corresponding Author
Dr. Vijayashree Priyadharsini. J,
Assistant Professor, Department of Microbiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University,
Chennai-600077, India.
E-mail: vijayashreej.sdc@saveetha.com
Received: October 30, 2019; Accepted: November 28, 2019; Published: November 30, 2019
Citation: Aklesha Behera, Vijayashree Priyadharsini J, Abilasha R. Computational approach towards Identification of Functional Mutations in Il-6 Cytokine Family and It’s Putative Association with Head and Neck Squamous Cell Carcinoma. Int J Dentistry Oral Sci. 2019;S6:02:002:5-10. doi: dx.doi.org/10.19070/2377-8075-SI02-06002
Copyright: Vijayashree Priyadharsini. J© 2019. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Background and Aim: Objectives: The present study aimed to identify alterations in the IL-6 family to derive a putative association with HNSCC (head
and neck squamous cell carcinoma).
Subjects and Methods: Computational approaches have been used to find the functional mutation in the IL-6 family. The cBioportal
database served as the primary source of data for analyzing the mutations. The TCGA (The Cancer Gene Atlas, Firehose
legacy) dataset encompassing 504 samples of HNSCC patients were included in the study.
Results: Alterations were observed in CLCF1 (7%), CNTF (2.4%), CTF 1(0.2%), IL-6 (2.2%), IL-11 (0.8%), LTF (1%), OSM
(0.6%) genes. Further, we found that three out of four mutations exhibited deleterious consequences, and one out of four missense
variants exhibited neutral effect upon substitution of glycine with amino acid serine.
Conclusion: Experimental validation is warranted to draw a strong association between the gene alterations and disease phenotype.
Dental implication: Identification of genetic alterations in crucial genes would aid in the selection of genetic markers with strong
association with HNSCC.
2.Introduction
3.Materials and Methods
4.Results
5.Discussion
6.Conclusions
7.References
Keywords
HNSCC; In Silico; IL-6; Mutations; Polymorphisms; Biomarkers.
Introduction
Head and neck squamous cell carcinoma (HNSCC) is a biologically
diverse and genomically heterogeneous disease that arises
from the squamous cell carcinoma lining of the upper aerodigestive
tract including lip and oral cavity coma nasal cavity, paranasal
sinuses, nasopharynx oropharynx larynx and hypopharynx [1-2].
Worldwide, HNSCC for more than 650000 cases and 340000
deaths annually [3]. In the United States itself, head and neck cancer
accounts for 3% of malignancy with almost 53000 American
developing head and neck cancer annually and 10800 equal then
comes the disease [4]. In Europe, the numbers are even higher. In
2012, new cases accounted for 250000 and 63500 deaths. In Indian
scenario, head and neck cancer accounts for 30% of all cancers.
HNSCC is a multifactorial disease but usually caused due to
tobacco and tobacco related products. The main risk factors associated
with head and neck squamous cell carcinoma are environmental
and lifestyle factors, culture of chewing tobacco, alcohol
consumption and smoking. Recent epidemiological studies have
associated human papillomavirus with head and neck carcinoma
[5]. Interleukin 6 is a pleiotropic which plays an important role in
a number of cellular processes including proliferation, survival
differentiation, migration and invasion and is located on chromosome
7. IL-6 is a multifunctional cytokine with both anti-inflammatory
and proinflammatory properties. IL-6 regulates progression
and tumor metastasis by modulating tumor angiogenesis and
tumor lymphangiogenesis studies have proved that IL-6 levels are
exponentially upgraded in cancer patients. According to the findings made by researchers, it has been discovered that IL-6 can lead
to cancer initiation and progression [6].
Materials and Methods
The cBioportal database hosts several datasets on HNSCC of
which the TCGA-Firehose Legacy was selected for the present
study. The demographic details of the patients in the dataset is
given in table 1. A total of 504 whole genome sequences with
mutation and copy number variants information from a total of
528 HNSCC samples were analysed to identify the mutations in
the genes of the IL-6 pathway.
Bioportal is an exhaustive collection of molecular profiling information
from cancer tissues and cell lines [7, 8], The database
is easy to use/user friendly and host genetic epigenetic and proteomic
information of the registered cases. The sample data includes
the sequence information of 528 HNSCC patients which
is used for the study.
A single query for mutation analysis was initiated by selecting the
OSCC cases from cBioportal database. The case data set included
528 sequenced tumors out of which 504 were analyzed for mutations
in genes associated with IL-6 signaling pathway. The gene
cluster included CLCF1, CNTF, CTF1, CTF2P, IL-6, IL-11, LIF,
OSM. The set of genes were user defined and entered into the
query.
The interactions of protein encoded by the gene with the highest
frequency of mutation was assessed by submitting the query
protein in the STRING v10.5 pipeline (https://string-db.org/
cgi/input.pl?sessionId=TLDBRo1NeAXZ&input_page_show_
search=on) [9].
The genome aggregation database (gnomAD) is an exhaustive
collection of data spanning 125, 748 exome sequences and 15,708
whole genome sequences from unrelated individuals sequenced
and deposited as part of various disease-specific or population
genetic studies. This data source was used to verify whether the
variants identified in the present study are reported elsewhere in
the other populations. The search could also provide an insight
about the minor allele frequency of the variants in the population
by which nature of the variants can be ascertained (Version 4,
2020) (Table 2) [10].
The I-Mutant server [11] was used for prediction of protein stability
changes upon single nucleotide mutations leading to change
in the amino acid being encoded by the triplet codon. The server
uses either protein sequence or structure to predict stabilization
and destabilization of protein structure in the majority of cases.
The prediction was based on running the query with protein sequence
downloaded in the FASTA format from the public domain (https://www.ncbi.nlm.nih.gov/protein/). Upon substitution
with the variant amino acid the stability changes were further
assessed using the free energy stability change (ΔΔG) value. A
value less than 0 and greater than 0 implies decrease and increase
in protein stability respectively (Table 3).
PROVEAN (Protein Variation Effect Analyzer) [12] predicts the
impact on the biological function of a protein upon substitution
with a amino acid (Table 2). The present analysis employs a user
defined query of missense variants entered along with the reference
sequence obtained from the NCBI database with a default
cut-off value of -2.5. The results returned scores based on amino
acid substitutions and classified them as either neutral or deleterious
depending on the PROVEAN scores. A score less than -2.5
or greater than -2.5 was considered to be deleterious and neutral
respectively (Table 3).
Table 1. Demographic details of patients analyzed in the present study (as obtained from the cBioportal site - TCGA - Firehose legacy dataset).
Table 2. Type and frequency of gene alteration observed in the genes encoding proteins of the IL-6 pathway in HNSCC patients.
Table 3. Consequences of mutation on protein stability and associated pathogenicity as predicted by the IMutant suite and PROVEAN tools.
Results
Data was collected using computational methods. Demographic
details of the patients in the TCGA dataset if given in Table 1. The CLCF-1 gene has the majority of amplifications (7%). CNTF
1 has 1% amplification whereas CNTF accounted for 2.4% amplification.
Other members of the IL-6 gene families were computed
for functional mutations. CT2P observed no alteration
whatsoever. Most of the gene families showed amplification. IL1
(0.8%), IL-6 (2.2%), IL-6 and LIF is also one gene family where
mis-sense mutation along with gene amplification was observed
(1%) (Table 2; Figure 1 and 2). The consequence of mutations
on the proteins encoded by IL-6 and LIF genes were recorded
(Table 3). The protein protein interaction network for the gene
which demonstrated highest frequency of mutation was shown
in figure 3.
Figure 1. Oncoprint data demonstrating the alterations in IL-6 gene family. Red bars - represents gene amplification; blue bars - represents deep deletions; light green spots - represents missense mutations of unknown significance; grey bars - represent no alterations.
Figure 3. Protein interaction network of CLCF1 gene which presented with the highest frequency of gene alteration.
Discussion
Several different studies were carried out in our institutions pertaining
to the genetic and pathological analysis of oral cancer [13,
14]. A correlation was charted between both the ethnicities taking
age, habits and the gradation of neoplasm into consideration.
Grading of HNSCC was done according to WHO classification.
The classification [15] is as follows:
Grade I (G1): Well differentiated (low grade)
Grade II (G2): Moderately differentiated (intermediate grade)
Grade III (G3): Poorly differentiated or anaplastic (high grade)
Grade IV (G4): Undifferentiated (high grade)
Grade x (Gx): Grade cannot be assessed (undetermined grade).
Various computational approaches interpreted that several gene
alterations have been identified in the IL-6 family, most of which
are gene amplifications [16]. IL-6 and LIF genes show presence
of non-synonymous mutations in OSCC patients. The mutations
were found to be novel as assessed by the gnomAD database.
Among the four missense mutations three were found to decrease
the stability of the protein. Except for the G10S substitution in
IL-6 protein, other amino acid substitutions were found to be
deleterious. (Table 3) The highest frequency of alterations was
found in CLCF1 (Cardiotrophin like cytokine factor 1) gene [17].
The association of IL-6 with clinical parameters and oncological
outcomes in head and neck cancer has been studied greatly since
the last 20 years [18]. Several studies have shown that elevated levels
of IL-6 family genes have shown either increased mutation or
gene alterations. Previous studies have found out that IL-6 levels in serum is responsible for OSCC [19-22]. Most of the IL-6 family
genes demonstrated either increased mutation or amplification.
In previous studies it has been stated that IL-6 signalling is associated
with progression and treatment resistance of OSCC [24]. Although
certain studies reported negative association of IL-6 with
OSCC [24] certain other studies have shown positive association
with IL-6 gene which was shown to promote cancer metastasis by
inducing epithelial mesenchymal transition via the JAK- STAT3-
SNAIL signalling pathway [23].
In a previous study conducted, the prevalence of HNSCC in Hispanic
population was 7.5%. Factors like alcohol consumption, age,
sex and socioeconomic factors are responsible for OSCC [25]. In
a previous study correlations were made on polymorphism of alleles
of IL-6 with regards to tobacco and alcohol consumption
[24, 26]. No significant association was found in GC allele, but
CC allele showed significant association of OSCC if a person intakes
alcohol and tobacco regularly (Singh et al., 2015). Similar
results were procured in a study where patients consumed alcohol
and suffered from breast cancer [27-30]. Contrary to the previous
studies, a study was conducted where a positive association
was found between gene polymorphism in IL-6 with OSCC [28].
Various studies have been conducted where a positive association
was detected in which polymorphisms have led to progression of
oral cancer, breast cancer, prostate cancer and colorectal cancer
[31, 32]. Even though in the current study a disparity is observed
between the ethnicities, it is previously proven that HNSCC has
its definite path of propagation and that ethnicity is not a predisposing
factor for HNSCC initiation as well as progression [33,
34]. Several studies using computational approach have been carried
out to identify potential markers in crucial genes implicated
in tumorigenesis [35-40]. Hence such approach holds promising
while handling exhaustive collection of data to be probed in to
select a few markers of clinical significance.
Conclusion
All the genes of the
IL-6 family have undergone alterations precisely gene amplifications
and missense mutations. Further experimental studies are
required to arrive at an association between IL-6 gene and OSCC
in south Indian population.
References
- Noble DJ, Jefferies SJ. Squamous cell carcinoma of the oral cavity, oropharynx and upper oesophagus. Medicine. 2019; 47: 269–74.
- Gupta V, Ramani P. Histologic and immunohistochemical evaluation of mirror image biopsies in oral squamous cell carcinoma. J Oral Biol Craniofac Res. 2016; 6(3):194-197. PMID: 27761383.
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394-424. PMID: 30207593.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1): 7-30. PMID: 31912902.
- Day AT, Dahlstrom KR, Lee R, Karam-Hage M, Sturgis EM. Impact of a tobacco treatment program on abstinence and survival rates among current smokers with head and neck squamous cell carcinoma. Head Neck. 2020; 42(9): 2440-2452. PMID: 32476217.
- St John MA, Li Y, Zhou X, Denny P, Ho CM, Wenyuan Shi, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004; 130(8): 929-35. PMID: 15313862.
- Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Bülent Arman Aksoy, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5): 401–4. PMID: 22588877.
- Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, S Onur Sumer, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6(269): l1. PMID: 23550210.
- Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Jaime Huerta-Cepas, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019; 47(D1): D607-D613. PMID: 30476243.
- Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Qingbo Wang, et al. Genome Aggregation Database Consortium, Neale BM, Daly MJ, MacArthur DG. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020 May; 581(7809): 434-443. PMID: 32461654.
- Capriotti E, Fariselli P, Casadio R. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005; 33: W306-10. PMID: 15980478.
- Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015; 31(16): 2745-7. PMID: 25851949.
- Jayaraj G, Sherlin HJ, Ramani P, Premkumar P, Natesan A. Stromal myofibroblasts in oral squamous cell carcinoma and potentially malignant disorders. Indian J Cancer. 2015; 52(1): 87-92. PMID: 26837985.
- Jayaraj G, Sherlin HJ, Ramani P, Premkumar P, Anuja N. Cytomegalovirus and Mucoepidermoid carcinoma: A possible causal relationship? A pilot study. J Oral Maxillofac Pathol. 2015; 19(3): 319-24. PMID: 26980959.
- Akhter M, Hossain S, Rahman QB, Molla MR. A study on histological grading of oral squamous cell carcinoma and its co-relationship with regional metastasis. J Oral Maxillofac Pathol. 2011; 15(2): 168-76. PMID: 22529575.
- Gheena S, Ezhilarasan D. Syringic acid triggers reactive oxygen species-mediated cytotoxicity in HepG2 cells. Hum Exp Toxicol. 2019; 38(6): 694- 702. PMID: 30924378.
- Hannah.R, Pratibha R, Herald.JS, Gheena R, Abilasha R, Jayaraj G, et al. Awareness about the use, Ethics and Scope of Dental Photography among Undergraduate Dental Students Dentist Behind the lens. Research J. Pharm. and Tech. 2018; 11(3): 1012-1016.
- Guo Y, Xu F, Lu T, Duan Z, Zhang Z. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012; 38(7): 904-10. PMID: 22651903.
- Sridharan G, Ramani P, Patankar S, Vijayaraghavan R. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma. J Oral Pathol Med. 2019; 48(4): 299-306. PMID: 30714209.
- Sridharan G, Ramani P, Patankar S. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma. J Cancer Res Ther. 2017; 13(3): 556-561. PMID: 28862226.
- Jinno T, Kawano S, Maruse Y, Matsubara R, Goto Y, Taiki Sakamoto, et al. Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma. Oncol Rep. 2015; 33(5): 2161-8. PMID: 25761055.
- Thangaraj SV, Shyamsundar V, Krishnamurthy A, Ramani P, Ganesan K, Muthulakshmi Muthuswami, et al. Molecular Portrait of Oral Tongue Squamous Cell Carcinoma Shown by Integrative Meta-Analysis of Expression Profiles with Validations. PLoS One. 2016; 11(6): e0156582. PMID: 27280700.
- Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res. 2011; 9(12): 1658-67. PMID: 21976712.
- Singh PK, Chandra G, Bogra J, Gupta R, Kumar V, Jain A, et al. Association of interleukin-6 genetic polymorphisms with risk of OSCC in Indian population. Meta Gene. 2015; 4: 142-51. PMID: 26005639/
- Schrank TP, Han Y, Weiss H, Resto VA. Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States--possible role for human papillomavirus in survival disparities. Head Neck. 2011; 33(1): 45-53. PMID: 20848419.
- Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med. 1995; 24(10): 450-3. PMID: 8600280.
- Balasubramanian SP, Azmy IA, Higham SE, Wilson AG, Cross SS, Cox A, et al. Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer. 2006; 6: 188. PMID: 16842617.
- Vairaktaris E, Yiannopoulos A, Vylliotis A, Yapijakis C, Derka S, S Vassiliou, et al. Strong association of interleukin-6 -174 G>C promoter polymorphism with increased risk of oral cancer. Int J Biol Markers. 2006; 21(4):246-50. PMID: 17177164.
- Wang YF, Chang SY, Tai SK, Li WY, Wang LS. Clinical significance of interleukin- 6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck. 2002; 24(9): 850-8. PMID: 12211049.
- Lagmay JP, London WB, Gross TG, Termuhlen A, Sullivan N, Amy Axel, et al. Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor). Clin Cancer Res. 2009; 15(16): 5234-9. PMID: 19671870.
- Landi S, Gemignani F, Bottari F, Gioia-Patricola L, Guino E, María Cambray, et al. Polymorphisms within inflammatory genes and colorectal cancer. J Negat Results Biomed. 2006; 5: 15. PMID: 17062130.
- Mandal S, Abebe F, Chaudhary J. -174G/C polymorphism in the interleukin- 6 promoter is differently associated with prostate cancer incidence depending on race. Genet Mol Res. 2014; 13(1):139-51. PMID: 24446297.
- Harris GJ, Clark GM, Von Hoff DD. Hispanic patients with head and neck cancer do not have a worse prognosis than Anglo-American patients. Cancer. 1992; 69(4): 1003-7. PMID: 1735067.
- Swathy. S, Gheena. S, Sri Varsha. L. Prevalence of pulp stones in patients with history of cardiac diseases. Research J Pharm and Tech. 2015; 8(12): 1625-1628.
- Jayaseelan VP, Arumugam P. Virtual screening of mutations in antioxidant genes and its putative association with HNSCC: An in silico approach. Mutat Res. 2020 Jun 9; 821: 111710. PMID: 32593872./
- Anita R, Paramasivam A, Priyadharsini JV, Chitra S. The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients. Am J Cancer Res. 2020; 10(8): 2546- 2554. PMID: 32905518.
- Dhivyadharshini J, Girija ASS, Paramasivam A, Priyadharsini JV. Decoding the Genetic Alterations in PRAME Gene Family and Its Association with Head and Neck Squamous Cell Carcinoma. Journal of Pharmaceutical Research International. 2020: 32(20): 93-102.
- Nirubama K, Girija ASS, Paramasivam A, Priyadharsini JV. Genetic Aberrations in Caspase Family of Genes and Their Possible Association with HNSCC. Journal of Pharmaceutical Research International. 2020: 32(15): 83-95.
- Sivarajan M, Girija ASS, Paramasivam A, Priyadharsini JV. Computational Approach to Identify Mutations in Genes of Notch Signaling Pathway and Its Association with OSCC. Journal of Pharmaceutical Research International. 2020; 32(20): 84-92.
- Akshayaa L, Girija ASS, Paramasivam A, Priyadharsini JV. Deciphering the Genetic Aberrations in DNA Damage Response Genes and Their Possible Association with HNSCC. Journal of Pharmaceutical Research International, 2020; 32(15): 156-169.